Fujioka M, Suzuki H
Br J Pharmacol. 1985 Feb;84(2):489-97. doi: 10.1111/j.1476-5381.1985.tb12933.x.
The effects of amosulalol, a newly synthesized sulphonamide-substituted phenylethylamine derivative, on electrical responses of smooth muscle cells of the guinea-pig vascular tissues to noradrenaline, isoprenaline and perivascular nerve stimulation were investigated. Amosulalol (10(-10) -10(-5)M) did not alter the resting membrane potential of smooth muscle cells of the mesenteric artery, the mesenteric vein, the main pulmonary artery and the portal vein. In the mesenteric artery, main pulmonary artery and portal vein, but not in the mesenteric vein, membrane depolarizations produced by noradrenaline were antagonized by amosulalol. In the portal vein, membrane hyperpolarizations produced by isoprenaline were antagonized by amosulalol. In the mesenteric artery, amosulalol (over 10(-6)M) enhanced the amplitude of excitatory junction potentials (e.j.ps) produced by perivascular nerve stimulation. Amosulalol antagonized the noradrenaline-induced decrease in the e.j.p. amplitude; this effect was much weaker than that of phentolamine. Amosulalol also antagonized the isoprenaline-induced enhancement of the e.j.p. amplitude. In the mesenteric vein, the slow depolarizations produced by perivascular nerve stimulation were depressed by amosulalol (over 10(-6)M), but the effect was much weaker than that of prazosin, yohimbine or phentolamine. Actions of amosulalol on electrical properties of vascular tissues can be summarized as follows: amosulalol blocks alpha 1- and beta-adrenoceptors. It also blocks alpha 2-adrenoceptors, though weakly.
研究了新合成的磺酰胺取代苯乙胺衍生物阿罗洛尔对豚鼠血管组织平滑肌细胞对去甲肾上腺素、异丙肾上腺素及血管周围神经刺激的电反应的影响。阿罗洛尔(10⁻¹⁰ - 10⁻⁵M)不改变肠系膜动脉、肠系膜静脉、主肺动脉和门静脉平滑肌细胞的静息膜电位。在肠系膜动脉、主肺动脉和门静脉中,而非肠系膜静脉中,阿罗洛尔可拮抗去甲肾上腺素引起的膜去极化。在门静脉中,阿罗洛尔可拮抗异丙肾上腺素引起的膜超极化。在肠系膜动脉中,阿罗洛尔(超过10⁻⁶M)可增强血管周围神经刺激产生的兴奋性接头电位(e.j.ps)的幅度。阿罗洛尔可拮抗去甲肾上腺素引起的e.j.p.幅度降低;此效应比酚妥拉明弱得多。阿罗洛尔还可拮抗异丙肾上腺素引起的e.j.p.幅度增强。在肠系膜静脉中,阿罗洛尔(超过10⁻⁶M)可抑制血管周围神经刺激产生的缓慢去极化,但该效应比哌唑嗪、育亨宾或酚妥拉明弱得多。阿罗洛尔对血管组织电特性的作用可总结如下:阿罗洛尔阻断α₁和β肾上腺素能受体。它也可阻断α₂肾上腺素能受体,尽管作用较弱。